Abiopharma

🔍 SKULE JEREMY (Executive)

Company: NASDAQ, INC. (NDAQ)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 2,250 shares of Common Stock, par value $0.01 per share at $94.75 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: false | shares_owned_after: 102,323.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: The reported sale was effected pursuant to a Rule 10b5-1(c) trading plan adopted on May 7, 2026.
• F2: The price reported in this box is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.00, inclusive. The reporting person undertakes to provide to the Issuer, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: Represents (i) 35,529 shares or units of restricted stock, of which 9,569 are vested, (ii) 63,075 shares of Common Stock underlying PSUs, 55,049 of which are vested, and (iii) 3,719 shares of Common Stock purchased under the Issuer's Employee Stock Purchase Plan.